T. M. Bonde, “Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists”, AO, vol. 62, no. 12, pp. 1815–1821, Dec. 2023.